| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-12 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-09 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-09 |
| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-08 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |
| mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
4e-08 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-07 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |
| mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |